Tag: oncologists market statistics

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Oncologists Market Size And Revenue Forecast Through 2030

The oncologists market, valued at $20.21 billion in 2025, is projected to experience an upward trajectory, reaching an estimated $21.09 billion by 2026, reflecting a compound annual growth rate of 4.4%. Factors contributing to this expansion historically include a global increase in cancer cases, heightened demand for expert cancer treatment services, the proliferation of healthcare facilities, improvements in medical imaging for diagnosis, and a greater emphasis on identifying cancer at its earliest stages.

The global oncologists market is projected to experience consistent expansion, reaching an estimated value of $25.07 billion by the year 2030, with a projected compound annual growth rate (CAGR) of 4.4%. This anticipated growth throughout the forecast period is fueled by several key factors, including the increasing prevalence of personalized and targeted cancer treatments, the broader acceptance of digital solutions for oncology management, advancements in immunotherapy and targeted therapy technologies, the establishment of more oncology centers in developing economies, and a heightened utilization of genomics and molecular diagnostics to guide treatment strategies. Important market trends anticipated during this timeframe involve a greater embrace of digital oncology platforms for patient oversight, a deeper integration of artificial intelligence and machine learning in cancer detection processes, the expanding implementation of precision medicine and genomic profiling for tailored cancer therapies, a surge in automated processes for chemotherapy preparation and drug administration, and a growing reliance on IoT-enabled systems for the monitoring of both oncology equipment and patient-related data.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9474&type=smp

Oncologists Market Growth Factors Supporting Long-Term Expansion

The increasing incidence of cancer is anticipated to be a significant driver for the oncologists market in the future. Cancer, a condition characterized by aberrant cell growth and dissemination throughout the body, is becoming more common. The term “prevalence” in this context signifies the count of new cancer diagnoses within a defined population over a specific timeframe. Oncologists are medical professionals dedicated to the detection and management of cancer, engaging in patient examination, diagnostic procedures, and the formulation of treatment strategies. To illustrate, data from the National Cancer Institute, a U.S. governmental body, reported approximately 18.1 million individuals as cancer survivors in the United States as of May 2024. This number is forecast to surge to 22.5 million by the year 2032. Projections for 2040 indicate an annual incidence of 29.9 million new cancer cases, with an estimated escalation in cancer-related fatalities to 15.3 million. Consequently, the escalating rate of cancer occurrences is fueling growth within the oncologists market.

Oncologists Market Categorization By Product Type And Application

The oncologists market covered in this report is segmented –

1) By Cancer Diagnostics And Treatment: Cancer Diagnostics, Cancer Treatment

2) By Indication: Lungs Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer, Bladder Cancer, Head And Neck Cancer, Prostate Cancer, Other Indications

3) By End Use: Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Specialty Clinics, Academia, Other End Uses

Subsegments:

1) By Cancer Diagnostics: Imaging Tests, Biopsy, Blood Tests, Molecular Diagnostics, Genetic Testing

2) By Cancer Treatment: Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy, Hormone Therapy, Stem Cell Transplant

Oncologists Market Industry Trends Shaping Future Revenue Growth

Key players within the oncologists market are prioritizing the establishment of AI-driven precision oncology centers, aiming to elevate personalized cancer therapies, sharpen diagnostic precision, and refine treatment strategies according to unique patient profiles and tumor attributes. These AI-precision oncology centers represent dedicated healthcare facilities employing artificial intelligence and machine learning to deliver exceptionally tailored cancer care. As an illustration, in early 2024, the Apollo Cancer Centre in India inaugurated its own specialized center. This facility is designed to empower oncologists, patients, and their support networks to achieve optimal results within specified periods by harnessing the extensive capabilities of AI. The center leverages AI technologies for highly accurate diagnoses and immediate comprehension of a patient’s health status, thereby enabling prompt actions and superior management of oncological cases, while also performing thorough cancer risk evaluations to pinpoint individuals who could gain from targeted drug treatments or immunotherapy integrated into their care regimens.

Oncologists Market Company Landscape And Strategic Competition

Major companies operating in the oncologists market are Abramson Cancer Center, MD Anderson Cancer Center of the University of Texas, Lilavati Hospital & Research Centre, Mount Elizabeth Hospital, Mount Miriam Cancer Hospital, Charité – Universitätsmedizin Berlin, General Electric Healthcare, F. Hoffmann-La Roche AG, Pfizer Inc., Bayer AG, Merck & Co. Inc., AbbVie Inc., Amgen Inc., Takeda Pharmaceuticals USA Inc., Becton Dickinson and Company, Cook Medical LLC, Terumo Corporation, AngioDynamics Inc., Thermo Fisher Scientific Inc., Illumina Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, Eli Lilly and Company, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Incyte Corporation, Seattle Genetics Inc.

Access The Complete Oncologists Market Report:

https://www.thebusinessresearchcompany.com/report/oncologists-global-market-report

Oncologists Market Largest Region: Which Geography Holds The Highest Market Share?

North Americawas the largest region in the oncologists market in 2025. The regions covered in the oncologists market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Growth In Market Size Of The Oncologists Market During 2026–2030?

The market size for oncologists has demonstrated consistent growth over recent years. This market is projected to expand from $20.21 billion in 2025 to $21.09 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 4.4%. Historically, this expansion has been driven by the rising incidence of cancer globally, growing demand for specialized oncology care, the expansion of hospital and clinic networks, advancements in diagnostic imaging technologies, and increasing awareness of early cancer detection.

The oncologists market size is anticipated to experience consistent expansion over the upcoming years. It is projected to reach $25.07 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.4%. This projected growth during the forecast period stems from factors such as the rise of personalized and targeted cancer treatments, the uptake of digital solutions for oncology management, advancements in immunotherapy and targeted therapy technologies, the establishment of more oncology centers in developing regions, and the escalating application of genomics and molecular diagnostics for designing treatment plans. Key developments during this period encompass the increasing integration of digital oncology platforms for managing patients, the growing incorporation of AI and machine learning in cancer detection, the expanded deployment of precision medicine and genomic profiling for tailored cancer treatment, the surging automation in preparing chemotherapy and delivering drugs, and the enhanced IoT-enabled oversight of oncology equipment and patient information.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9474&type=smp

Which Drivers Are Advancing The Oncologists Market Growth?

The increasing occurrence of cancer is anticipated to boost the oncologists market in the future. Cancer is defined as an illness where certain body cells multiply without control and extend to other areas. Cancer prevalence indicates the count of newly diagnosed cancer instances emerging within a particular population over a specific timeframe. Oncologists are medical professionals specializing in the identification and management of cancer. Their responsibilities include patient examination, cancer diagnosis, and determining appropriate treatment strategies. As an illustration, in May 2024, data from the National Cancer Institute, a US-based government agency, revealed approximately 18.1 million cancer survivors in the United States. This number is forecast to reach 22.5 million by 2032. By 2040, annual new cancer cases are expected to total 29.9 million, and cancer-related fatalities are projected to climb to 15.3 million. Consequently, the rising incidence of cancer is propelling the oncologists market.

What Are The Core Segment Classifications In The Oncologists Market?

The oncologists market covered in this report is segmented –

1) By Cancer Diagnostics And Treatment: Cancer Diagnostics, Cancer Treatment

2) By Indication: Lungs Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer, Bladder Cancer, Head And Neck Cancer, Prostate Cancer, Other Indications

3) By End Use: Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Specialty Clinics, Academia, Other End Uses

Subsegments:

1) By Cancer Diagnostics: Imaging Tests, Biopsy, Blood Tests, Molecular Diagnostics, Genetic Testing

2) By Cancer Treatment: Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy, Hormone Therapy, Stem Cell Transplant

What Trends Are Affecting The Growth Of The Oncologists Market?

Leading companies active in the omics-based clinical trials market are emphasizing innovative solutions, such as HiFi sequencing technology, to elevate the accuracy, speed, and depth of multi-omics data analysis, ultimately leading to enhanced trial outcomes and personalized treatment strategies. HiFi sequencing is defined as a next-generation sequencing (NGS) method that generates long, highly accurate reads through circular consensus sequencing (CCS), thereby allowing for comprehensive and precise examination of genomes, transcriptomes, and epigenomes. As an example, in October 2024, Pacific Biosciences of California Inc., a US-based biotechnology company, partnering with the Agency for Science, Technology, and Research (A*STAR), a Singapore-based research and product development agency, and Macrogen Inc., a South Korea-based biotechnology company, inaugurated a cutting-edge lab to expedite genomics innovation in Singapore utilizing advanced long-read sequencing technology. This facility allows researchers to perform sophisticated genomic studies with greater precision and rapidity. It accommodates a wide array of applications, including whole genome sequencing, transcriptomics, epigenetics, and metagenomics. The lab further encourages cooperative efforts among global scientists and local institutions, with the goal of accelerating discoveries in personalized medicine, rare disease diagnostics, and precision oncology. Additionally, it provides training programs and shared access to high-throughput sequencing infrastructure, contributing to capacity-building and innovation within the Asia-Pacific region.

Which Key Players Are Active In The Oncologists Market?

Major companies operating in the oncologists market are Abramson Cancer Center, MD Anderson Cancer Center of the University of Texas, Lilavati Hospital & Research Centre, Mount Elizabeth Hospital, Mount Miriam Cancer Hospital, Charité – Universitätsmedizin Berlin, General Electric Healthcare, F. Hoffmann-La Roche AG, Pfizer Inc., Bayer AG, Merck & Co. Inc., AbbVie Inc., Amgen Inc., Takeda Pharmaceuticals USA Inc., Becton Dickinson and Company, Cook Medical LLC, Terumo Corporation, AngioDynamics Inc., Thermo Fisher Scientific Inc., Illumina Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, Eli Lilly and Company, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Incyte Corporation, Seattle Genetics Inc.

Access The Complete Oncologists Market Report:

https://www.thebusinessresearchcompany.com/report/oncologists-global-market-report

Which Region Stands As The Largest Contributor To The Oncologists Market?

North America was the largest region in the oncologists market in 2025. The regions covered in the oncologists market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Oncologists Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=9474&type=smp

Browse Through More Reports Similar to the Global Oncologists Market 2026, By The Business Research Company

Asphalt Additives Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/asphalt-additives-global-market-report

Asphalt Pavers Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/asphalt-pavers-global-market-report

Polymer Coated Fabrics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/polymer-coated-fabrics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Oncologists Market From 2026 To 2030?

The oncologists market size has experienced consistent expansion in recent years. This market is anticipated to expand from $20.21 billion in 2025 to $21.09 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 4.4%. The growth observed in the past can be attributed to the global rise in cancer incidence, increasing demand for specialized oncology care, the expansion of hospital and clinic networks, advancements in diagnostic imaging technologies, and growing awareness of early cancer detection.

The oncologists market size is projected to experience consistent expansion in the coming years. Its valuation is anticipated to reach $25.07 billion by 2030, expanding at a compound annual growth rate (CAGR) of 4.4%. This anticipated growth throughout the forecast period stems from several factors, including the advancement of personalized and targeted cancer treatments, the uptake of digital solutions for oncology management, breakthroughs in immunotherapy and targeted therapy technology, the proliferation of oncology centers in developing regions, and the escalating application of genomics and molecular diagnostics for tailoring treatment plans. Key developments expected during this period involve the increasing adoption of digital oncology platforms for patient care, greater integration of AI and machine learning in diagnosing cancer, the expanding use of precision medicine and genomic profiling for customized cancer therapies, a rise in automation for chemotherapy preparation and drug administration, and enhanced IoT-enabled monitoring of oncology equipment and patient information.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9474&type=smp

Which Strong Drivers Are Impacting The Oncologists Market Growth?

The expanding incidence of cancer is anticipated to drive the oncologists market in the future. Cancer is characterized as a condition where certain body cells multiply without control and disseminate to other regions. The prevalence of cancer signifies the count of new cancer diagnoses appearing within a defined population over a specific timeframe. Oncologists are medical professionals focused on the diagnosis and management of cancer. Their responsibilities include patient examination, cancer diagnosis, and determining appropriate treatment strategies. For example, the National Cancer Institute, a US-based government entity, reported approximately 18.1 million cancer survivors in the United States in May 2024. This count is projected to increase to 22.5 million by 2032. Furthermore, by 2040, annual new cancer cases are predicted to reach 29.9 million, with cancer-related fatalities expected to climb to 15.3 million. Consequently, the increasing prevalence of cancer is a key impetus for the oncologists market.

Which Segments Define The Oncologists Market Segment Structure?

The oncologists market covered in this report is segmented –

1) By Cancer Diagnostics And Treatment: Cancer Diagnostics, Cancer Treatment

2) By Indication: Lungs Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer, Bladder Cancer, Head And Neck Cancer, Prostate Cancer, Other Indications

3) By End Use: Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Specialty Clinics, Academia, Other End Uses

Subsegments:

1) By Cancer Diagnostics: Imaging Tests, Biopsy, Blood Tests, Molecular Diagnostics, Genetic Testing

2) By Cancer Treatment: Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy, Hormone Therapy, Stem Cell Transplant

Which Trends Are Contributing To Changes In The Oncologists Market?

Leading companies in the oncologists market are concentrating on establishing AI-precision oncology centers to advance personalized cancer treatment, enhance diagnostic accuracy, and optimize treatment strategies by utilizing individual patient data and tumor characteristics. These AI-precision oncology centers are specialized medical facilities that employ artificial intelligence (AI) and machine learning technologies to deliver highly individualized cancer care. As an example, in January 2024, Apollo Cancer Centre, a hospital based in India, launched its own Apollo Cancer Centre. This center is designed to support oncologists, patients, and caregivers in achieving optimal results within a defined period by leveraging the extensive capabilities of AI technology. The Precision Oncology Centre (POC) uses AI for accurate diagnoses and real-time insights into patient conditions, enabling timely interventions and improved management of cancer cases. Additionally, the center conducts comprehensive cancer risk assessments, assisting in identifying patients who may benefit from targeted therapies or immunotherapy as components of their treatment plans.

Who Are The Established Players Within The Oncologists Market?

Major companies operating in the oncologists market are Abramson Cancer Center, MD Anderson Cancer Center of the University of Texas, Lilavati Hospital & Research Centre, Mount Elizabeth Hospital, Mount Miriam Cancer Hospital, Charité – Universitätsmedizin Berlin, General Electric Healthcare, F. Hoffmann-La Roche AG, Pfizer Inc., Bayer AG, Merck & Co. Inc., AbbVie Inc., Amgen Inc., Takeda Pharmaceuticals USA Inc., Becton Dickinson and Company, Cook Medical LLC, Terumo Corporation, AngioDynamics Inc., Thermo Fisher Scientific Inc., Illumina Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, Eli Lilly and Company, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Incyte Corporation, Seattle Genetics Inc.

Get The Full Oncologists Market Report:

https://www.thebusinessresearchcompany.com/report/oncologists-global-market-report

Which Region Is The Leading Market For The Oncologists Market?

North America was the largest region in the oncologists market in 2025. The regions covered in the oncologists market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Oncologists Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/oncologists-global-market-report

Browse Through More Reports Similar to the Global Oncologists Market 2026, By The Business Research Company

Asphalt Additives Market Report 2026

https://www.thebusinessresearchcompany.com/report/asphalt-additives-global-market-report

Asphalt Pavers Market Report

https://www.thebusinessresearchcompany.com/report/asphalt-pavers-global-market-report

Polymer Coated Fabrics Market Report

https://www.thebusinessresearchcompany.com/report/polymer-coated-fabrics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Oncologists Market Expected To Change Between 2026 And 2030?

The oncologists market size has seen steady growth in recent years. It is anticipated to expand from $20.21 billion in 2025 to $21.09 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.4%. The factors contributing to this growth in the past include the increasing worldwide incidence of cancer, a rising demand for specialized oncology treatments, the expansion of hospital and clinic networks, improvements in diagnostic imaging technologies, and enhanced awareness of early cancer detection.

The oncologists market size is projected to experience consistent expansion in the coming years. This market is anticipated to reach $25.07 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.4%. This anticipated expansion throughout the forecast period stems from several factors, including the advancement of personalized and targeted cancer treatments, the uptake of digital solutions for oncology management, breakthroughs in immunotherapy and targeted therapy technologies, the establishment of more oncology centers in developing regions, and the greater application of genomics and molecular diagnostics for tailoring treatment plans. Key trends during this period encompass the growing use of digital oncology platforms for managing patients, a rise in the integration of AI and machine learning for cancer diagnosis, the expanding deployment of precision medicine and genomic profiling for customized cancer treatment, increased automation in the preparation and delivery of chemotherapy, and greater IoT-enabled surveillance of oncology equipment and patient information.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9474&type=smp

Which Major Factors Are Driving The Expansion Of The Oncologists Market?

The increasing incidence of cancer is anticipated to boost the oncologists market in the future. Cancer is defined as a condition where certain body cells multiply without control and extend to different regions. The prevalence of cancer denotes the quantity of new cancer diagnoses appearing within a defined population over a particular timeframe. Oncologists are medical professionals specializing in identifying and treating cancer. Their roles include patient examination, cancer diagnosis, and determining suitable treatment plans. As an example, in May 2024, the National Cancer Institute, a US-based government entity, reported approximately 18.1 million cancer survivors in the United States. This number is forecasted to increase to 22.5 million by 2032. By 2040, new annual cancer cases are predicted to reach 29.9 million, and cancer-related fatalities are projected to grow to 15.3 million. Consequently, the increasing incidence of cancer is a key driver for the oncologists market.

How Is The Oncologists Market Structured Across Different Segments?

The oncologists market covered in this report is segmented –

1) By Cancer Diagnostics And Treatment: Cancer Diagnostics, Cancer Treatment

2) By Indication: Lungs Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer, Bladder Cancer, Head And Neck Cancer, Prostate Cancer, Other Indications

3) By End Use: Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Specialty Clinics, Academia, Other End Uses

Subsegments:

1) By Cancer Diagnostics: Imaging Tests, Biopsy, Blood Tests, Molecular Diagnostics, Genetic Testing

2) By Cancer Treatment: Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy, Hormone Therapy, Stem Cell Transplant

What Key Trends Are Influencing The Development Of The Oncologists Market?

Leading companies in the oncologists market are concentrating on establishing AI-precision oncology centers to enhance personalized cancer care, improve diagnostic accuracy, and optimize treatment plans based on individual patient data and tumor characteristics. AI-precision oncology centers are defined as specialized medical facilities that employ artificial intelligence (AI) and machine learning technologies to deliver highly individualized cancer treatment. For instance, in January 2024, Apollo Cancer Centre, an India-based hospital, launched Apollo Cancer Centre. This center is designed to assist oncologists, patients, and caregivers in achieving the best possible outcomes within a defined timeframe by leveraging the extensive potential of AI technology. The center utilizes AI technologies to provide precise diagnoses and real-time insights into patient conditions. This capability allows for timely interventions and improved management of cancer cases. Additionally, the centre conducts comprehensive cancer risk assessments, helping to identify patients who may benefit from targeted therapies or immunotherapy as part of their treatment plans.

Which Major Players Dominate The Oncologists Market?

Major companies operating in the oncologists market are Abramson Cancer Center, MD Anderson Cancer Center of the University of Texas, Lilavati Hospital & Research Centre, Mount Elizabeth Hospital, Mount Miriam Cancer Hospital, Charité – Universitätsmedizin Berlin, General Electric Healthcare, F. Hoffmann-La Roche AG, Pfizer Inc., Bayer AG, Merck & Co. Inc., AbbVie Inc., Amgen Inc., Takeda Pharmaceuticals USA Inc., Becton Dickinson and Company, Cook Medical LLC, Terumo Corporation, AngioDynamics Inc., Thermo Fisher Scientific Inc., Illumina Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, Eli Lilly and Company, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Incyte Corporation, Seattle Genetics Inc.

Read the full oncologists market report here:

https://www.thebusinessresearchcompany.com/report/oncologists-global-market-report

Which Region Currently Holds The Largest Share Of The Oncologists Market?

North America was the largest region in the oncologists market in 2025. The regions covered in the oncologists market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Oncologists Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9474&type=smp

Browse Through More Reports Similar to the Global Oncologists Market 2026, By The Business Research Company

Asphalt Additives Global Market Report

https://www.thebusinessresearchcompany.com/report/asphalt-additives-global-market-report

Asphalt Pavers Global Market Report

https://www.thebusinessresearchcompany.com/report/asphalt-pavers-global-market-report

Polymer Coated Fabrics Global Market Report

https://www.thebusinessresearchcompany.com/report/polymer-coated-fabrics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Oncologists Market Expected To Change Between 2026 And 2030?

The oncologists market size has seen steady growth in recent years. It is anticipated to expand from $20.21 billion in 2025 to $21.09 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.4%. The factors contributing to this growth in the past include the increasing worldwide incidence of cancer, a rising demand for specialized oncology treatments, the expansion of hospital and clinic networks, improvements in diagnostic imaging technologies, and enhanced awareness of early cancer detection.

The oncologists market size is projected to experience consistent expansion in the coming years. This market is anticipated to reach $25.07 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.4%. This anticipated expansion throughout the forecast period stems from several factors, including the advancement of personalized and targeted cancer treatments, the uptake of digital solutions for oncology management, breakthroughs in immunotherapy and targeted therapy technologies, the establishment of more oncology centers in developing regions, and the greater application of genomics and molecular diagnostics for tailoring treatment plans. Key trends during this period encompass the growing use of digital oncology platforms for managing patients, a rise in the integration of AI and machine learning for cancer diagnosis, the expanding deployment of precision medicine and genomic profiling for customized cancer treatment, increased automation in the preparation and delivery of chemotherapy, and greater IoT-enabled surveillance of oncology equipment and patient information.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9474&type=smp

Which Major Factors Are Driving The Expansion Of The Oncologists Market?

The increasing incidence of cancer is anticipated to boost the oncologists market in the future. Cancer is defined as a condition where certain body cells multiply without control and extend to different regions. The prevalence of cancer denotes the quantity of new cancer diagnoses appearing within a defined population over a particular timeframe. Oncologists are medical professionals specializing in identifying and treating cancer. Their roles include patient examination, cancer diagnosis, and determining suitable treatment plans. As an example, in May 2024, the National Cancer Institute, a US-based government entity, reported approximately 18.1 million cancer survivors in the United States. This number is forecasted to increase to 22.5 million by 2032. By 2040, new annual cancer cases are predicted to reach 29.9 million, and cancer-related fatalities are projected to grow to 15.3 million. Consequently, the increasing incidence of cancer is a key driver for the oncologists market.

How Is The Oncologists Market Structured Across Different Segments?

The oncologists market covered in this report is segmented –

1) By Cancer Diagnostics And Treatment: Cancer Diagnostics, Cancer Treatment

2) By Indication: Lungs Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer, Bladder Cancer, Head And Neck Cancer, Prostate Cancer, Other Indications

3) By End Use: Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Specialty Clinics, Academia, Other End Uses

Subsegments:

1) By Cancer Diagnostics: Imaging Tests, Biopsy, Blood Tests, Molecular Diagnostics, Genetic Testing

2) By Cancer Treatment: Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy, Hormone Therapy, Stem Cell Transplant

What Key Trends Are Influencing The Development Of The Oncologists Market?

Leading companies in the oncologists market are concentrating on establishing AI-precision oncology centers to enhance personalized cancer care, improve diagnostic accuracy, and optimize treatment plans based on individual patient data and tumor characteristics. AI-precision oncology centers are defined as specialized medical facilities that employ artificial intelligence (AI) and machine learning technologies to deliver highly individualized cancer treatment. For instance, in January 2024, Apollo Cancer Centre, an India-based hospital, launched Apollo Cancer Centre. This center is designed to assist oncologists, patients, and caregivers in achieving the best possible outcomes within a defined timeframe by leveraging the extensive potential of AI technology. The center utilizes AI technologies to provide precise diagnoses and real-time insights into patient conditions. This capability allows for timely interventions and improved management of cancer cases. Additionally, the centre conducts comprehensive cancer risk assessments, helping to identify patients who may benefit from targeted therapies or immunotherapy as part of their treatment plans.

Which Major Players Dominate The Oncologists Market?

Major companies operating in the oncologists market are Abramson Cancer Center, MD Anderson Cancer Center of the University of Texas, Lilavati Hospital & Research Centre, Mount Elizabeth Hospital, Mount Miriam Cancer Hospital, Charité – Universitätsmedizin Berlin, General Electric Healthcare, F. Hoffmann-La Roche AG, Pfizer Inc., Bayer AG, Merck & Co. Inc., AbbVie Inc., Amgen Inc., Takeda Pharmaceuticals USA Inc., Becton Dickinson and Company, Cook Medical LLC, Terumo Corporation, AngioDynamics Inc., Thermo Fisher Scientific Inc., Illumina Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, Eli Lilly and Company, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Incyte Corporation, Seattle Genetics Inc.

Read the full oncologists market report here:

https://www.thebusinessresearchcompany.com/report/oncologists-global-market-report

Which Region Currently Holds The Largest Share Of The Oncologists Market?

North America was the largest region in the oncologists market in 2025. The regions covered in the oncologists market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Oncologists Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9474&type=smp

Browse Through More Reports Similar to the Global Oncologists Market 2026, By The Business Research Company

Asphalt Additives Global Market Report

https://www.thebusinessresearchcompany.com/report/asphalt-additives-global-market-report

Asphalt Pavers Global Market Report

https://www.thebusinessresearchcompany.com/report/asphalt-pavers-global-market-report

Polymer Coated Fabrics Global Market Report

https://www.thebusinessresearchcompany.com/report/polymer-coated-fabrics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Oncologists Market Expected To Change Between 2026 And 2030?

The oncologists market size has seen steady growth in recent years. It is anticipated to expand from $20.21 billion in 2025 to $21.09 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.4%. The factors contributing to this growth in the past include the increasing worldwide incidence of cancer, a rising demand for specialized oncology treatments, the expansion of hospital and clinic networks, improvements in diagnostic imaging technologies, and enhanced awareness of early cancer detection.

The oncologists market size is projected to experience consistent expansion in the coming years. This market is anticipated to reach $25.07 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.4%. This anticipated expansion throughout the forecast period stems from several factors, including the advancement of personalized and targeted cancer treatments, the uptake of digital solutions for oncology management, breakthroughs in immunotherapy and targeted therapy technologies, the establishment of more oncology centers in developing regions, and the greater application of genomics and molecular diagnostics for tailoring treatment plans. Key trends during this period encompass the growing use of digital oncology platforms for managing patients, a rise in the integration of AI and machine learning for cancer diagnosis, the expanding deployment of precision medicine and genomic profiling for customized cancer treatment, increased automation in the preparation and delivery of chemotherapy, and greater IoT-enabled surveillance of oncology equipment and patient information.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9474&type=smp

Which Major Factors Are Driving The Expansion Of The Oncologists Market?

The increasing incidence of cancer is anticipated to boost the oncologists market in the future. Cancer is defined as a condition where certain body cells multiply without control and extend to different regions. The prevalence of cancer denotes the quantity of new cancer diagnoses appearing within a defined population over a particular timeframe. Oncologists are medical professionals specializing in identifying and treating cancer. Their roles include patient examination, cancer diagnosis, and determining suitable treatment plans. As an example, in May 2024, the National Cancer Institute, a US-based government entity, reported approximately 18.1 million cancer survivors in the United States. This number is forecasted to increase to 22.5 million by 2032. By 2040, new annual cancer cases are predicted to reach 29.9 million, and cancer-related fatalities are projected to grow to 15.3 million. Consequently, the increasing incidence of cancer is a key driver for the oncologists market.

How Is The Oncologists Market Structured Across Different Segments?

The oncologists market covered in this report is segmented –

1) By Cancer Diagnostics And Treatment: Cancer Diagnostics, Cancer Treatment

2) By Indication: Lungs Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer, Bladder Cancer, Head And Neck Cancer, Prostate Cancer, Other Indications

3) By End Use: Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Specialty Clinics, Academia, Other End Uses

Subsegments:

1) By Cancer Diagnostics: Imaging Tests, Biopsy, Blood Tests, Molecular Diagnostics, Genetic Testing

2) By Cancer Treatment: Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy, Hormone Therapy, Stem Cell Transplant

What Key Trends Are Influencing The Development Of The Oncologists Market?

Leading companies in the oncologists market are concentrating on establishing AI-precision oncology centers to enhance personalized cancer care, improve diagnostic accuracy, and optimize treatment plans based on individual patient data and tumor characteristics. AI-precision oncology centers are defined as specialized medical facilities that employ artificial intelligence (AI) and machine learning technologies to deliver highly individualized cancer treatment. For instance, in January 2024, Apollo Cancer Centre, an India-based hospital, launched Apollo Cancer Centre. This center is designed to assist oncologists, patients, and caregivers in achieving the best possible outcomes within a defined timeframe by leveraging the extensive potential of AI technology. The center utilizes AI technologies to provide precise diagnoses and real-time insights into patient conditions. This capability allows for timely interventions and improved management of cancer cases. Additionally, the centre conducts comprehensive cancer risk assessments, helping to identify patients who may benefit from targeted therapies or immunotherapy as part of their treatment plans.

Which Major Players Dominate The Oncologists Market?

Major companies operating in the oncologists market are Abramson Cancer Center, MD Anderson Cancer Center of the University of Texas, Lilavati Hospital & Research Centre, Mount Elizabeth Hospital, Mount Miriam Cancer Hospital, Charité – Universitätsmedizin Berlin, General Electric Healthcare, F. Hoffmann-La Roche AG, Pfizer Inc., Bayer AG, Merck & Co. Inc., AbbVie Inc., Amgen Inc., Takeda Pharmaceuticals USA Inc., Becton Dickinson and Company, Cook Medical LLC, Terumo Corporation, AngioDynamics Inc., Thermo Fisher Scientific Inc., Illumina Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, Eli Lilly and Company, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Incyte Corporation, Seattle Genetics Inc.

Read the full oncologists market report here:

https://www.thebusinessresearchcompany.com/report/oncologists-global-market-report

Which Region Currently Holds The Largest Share Of The Oncologists Market?

North America was the largest region in the oncologists market in 2025. The regions covered in the oncologists market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Oncologists Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9474&type=smp

Browse Through More Reports Similar to the Global Oncologists Market 2026, By The Business Research Company

Asphalt Additives Global Market Report

https://www.thebusinessresearchcompany.com/report/asphalt-additives-global-market-report

Asphalt Pavers Global Market Report

https://www.thebusinessresearchcompany.com/report/asphalt-pavers-global-market-report

Polymer Coated Fabrics Global Market Report

https://www.thebusinessresearchcompany.com/report/polymer-coated-fabrics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the oncologists market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Oncologists Market expected to grow between 2026 and 2030?

The oncologists market size has seen steady expansion in recent years. It is anticipated to expand from $20.21 billion in 2025 to $21.09 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.4%. This historical growth can be credited to factors such as the rising incidence of cancer globally, the growing demand for specialized oncology care, the expansion of hospital and clinic networks, advancements in diagnostic imaging technologies, and increasing awareness of early cancer detection.

The oncologists market is projected to experience consistent expansion in the coming years. Its valuation is anticipated to reach $25.07 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.4%. This anticipated growth throughout the forecast period stems from advancements in personalized and targeted cancer treatments, the uptake of digital solutions for oncology management, innovations in immunotherapy and targeted therapy technologies, the proliferation of oncology centers in developing regions, and the growing application of genomics and molecular diagnostics for tailoring treatment strategies. Key developments expected during this period encompass the wider embrace of digital oncology platforms for managing patients, enhanced integration of AI and machine learning in diagnosing cancer, a greater emphasis on precision medicine and genomic profiling for customized cancer therapies, increased automation in the preparation of chemotherapy and drug administration, and expanded IoT-enabled surveillance of oncology equipment and patient information.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9474&type=smp

Which Drivers Are Influencing Market Acceleration In The Oncologists Market?

The increasing occurrence of cancer is anticipated to boost the oncologists market. Cancer is a condition where certain body cells multiply without control and spread. The prevalence of cancer denotes the incidence of new cases within a specific population over a period. Oncologists are medical professionals focused on diagnosing and treating cancer, performing examinations, identifying the disease, and determining treatment strategies. Illustratively, the National Cancer Institute reported approximately 18.1 million cancer survivors in the United States in May 2024. This number is projected to climb to 22.5 million by 2032. Furthermore, by 2040, annual new cancer cases are expected to hit 29.9 million, with cancer-related fatalities potentially increasing to 15.3 million. Consequently, the rising prevalence of cancer is a key factor driving demand in the oncologists market.

What Leading Segments Are Studied In The Oncologists Market?

The oncologists market covered in this report is segmented –

1) By Cancer Diagnostics And Treatment: Cancer Diagnostics, Cancer Treatment

2) By Indication: Lungs Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer, Bladder Cancer, Head And Neck Cancer, Prostate Cancer, Other Indications

3) By End Use: Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Specialty Clinics, Academia, Other End Uses

Subsegments:

1) By Cancer Diagnostics: Imaging Tests, Biopsy, Blood Tests, Molecular Diagnostics, Genetic Testing

2) By Cancer Treatment: Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy, Hormone Therapy, Stem Cell Transplant

How Are Emerging Trends Affecting The Progression Of The Oncologists Market?

Major companies operating in the oncologists market are focusing on implementing AI-precision oncology centers to enhance individualized cancer treatment, improve diagnostic accuracy, and optimize treatment strategies based on unique patient data and tumor characteristics. AI-precision oncology centers refer to specialized medical facilities that use artificial intelligence (AI) and machine learning technologies to deliver highly personalized cancer care. For instance, in January 2024, Apollo Cancer Centre, an India-based hospital, launched Apollo Cancer Centre. This facility is designed to support oncologists, patients, and caregivers in achieving the best possible outcomes within a defined timeframe by leveraging the extensive potential of AI technology. The centre employs AI technologies to provide precise diagnoses and real-time insights into patient conditions, which allows for timely interventions and more effective management of cancer cases. It also conducts comprehensive cancer risk assessments, helping to identify patients who may benefit from targeted therapies or immunotherapy as part of their treatment plans.

Which Key Market Players Are Investing In Expansion And Innovation Within The Oncologists Market?

Major companies operating in the oncologists market are Abramson Cancer Center, MD Anderson Cancer Center of the University of Texas, Lilavati Hospital & Research Centre, Mount Elizabeth Hospital, Mount Miriam Cancer Hospital, Charité – Universitätsmedizin Berlin, General Electric Healthcare, F. Hoffmann-La Roche AG, Pfizer Inc., Bayer AG, Merck & Co. Inc., AbbVie Inc., Amgen Inc., Takeda Pharmaceuticals USA Inc., Becton Dickinson and Company, Cook Medical LLC, Terumo Corporation, AngioDynamics Inc., Thermo Fisher Scientific Inc., Illumina Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, Eli Lilly and Company, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Incyte Corporation, Seattle Genetics Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/oncologists-global-market-report

Which Regions Are Projected To Dominate The Oncologists Market In The Coming Years?

North America was the largest region in the oncologists market in 2025. The regions covered in the oncologists market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Oncologists Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9474&type=smp

Browse Through More Reports Similar to the Global Oncologists Market 2026, By The Business Research Company

Oncology Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/oncology-drugs-market

Specialty Foods Market Report 2026

https://www.thebusinessresearchcompany.com/report/specialty-foods-global-market-report

Community Oncology Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/community-oncology-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model